HEADER TRANSFERASE 25-APR-22 7XM7 TITLE CRYSTAL STRUCTURE OF THE CBP IN COMPLEX WITH THE Y08188 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A, B, C, D; COMPND 4 EC: 2.3.1.48; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CBP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS BROMODOMAIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Q.XIANG,Y.ZHANG,C.WANG,M.SONG,Y.XU REVDAT 2 29-NOV-23 7XM7 1 REMARK REVDAT 1 22-JUN-22 7XM7 0 JRNL AUTH Q.XIANG,Y.ZHANG,C.WANG,M.SONG,Y.XU JRNL TITL DISCOVERY AND OPTIMIZATION OF 1-(1H-INDOL-1-YL)ETHANONE JRNL TITL 2 DERIVATIVES AS POTENT AND SELECTIVE CBP BROMODOMAIN JRNL TITL 3 INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.36 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0189 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.36 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 55.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.0 REMARK 3 NUMBER OF REFLECTIONS : 19012 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 993 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.36 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.42 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1399 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.43 REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE SET COUNT : 66 REMARK 3 BIN FREE R VALUE : 0.2380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3806 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.06000 REMARK 3 B22 (A**2) : -6.02000 REMARK 3 B33 (A**2) : 5.85000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.79000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.578 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.289 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.280 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.589 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.935 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.886 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4006 ; 0.012 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3637 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5435 ; 1.578 ; 1.996 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8475 ; 1.017 ; 3.003 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 449 ; 5.604 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 203 ;41.708 ;24.680 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 686 ;16.803 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;17.413 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 560 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4325 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 813 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7XM7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1300029168. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-NOV-18 REMARK 200 TEMPERATURE (KELVIN) : 197 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL19U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97906 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.32 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20023 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.360 REMARK 200 RESOLUTION RANGE LOW (A) : 90.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.20000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.36 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.35700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4NYX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350 0.2M NH4NO3 PH6.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.09000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7100 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7200 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1065 REMARK 465 LYS A 1066 REMARK 465 LYS A 1067 REMARK 465 GLY A 1068 REMARK 465 HIS A 1069 REMARK 465 HIS A 1070 REMARK 465 HIS A 1071 REMARK 465 HIS A 1072 REMARK 465 HIS A 1073 REMARK 465 HIS A 1074 REMARK 465 LEU A 1075 REMARK 465 VAL A 1076 REMARK 465 PRO A 1077 REMARK 465 ARG A 1078 REMARK 465 GLY A 1079 REMARK 465 SER A 1080 REMARK 465 ARG A 1081 REMARK 465 LYS A 1082 REMARK 465 LYS A 1083 REMARK 465 GLY A 1197 REMARK 465 MET B 1065 REMARK 465 LYS B 1066 REMARK 465 LYS B 1067 REMARK 465 GLY B 1068 REMARK 465 HIS B 1069 REMARK 465 HIS B 1070 REMARK 465 HIS B 1071 REMARK 465 HIS B 1072 REMARK 465 HIS B 1073 REMARK 465 HIS B 1074 REMARK 465 LEU B 1075 REMARK 465 VAL B 1076 REMARK 465 PRO B 1077 REMARK 465 ARG B 1078 REMARK 465 GLY B 1079 REMARK 465 SER B 1080 REMARK 465 ARG B 1081 REMARK 465 LYS B 1082 REMARK 465 GLY B 1197 REMARK 465 MET C 1065 REMARK 465 LYS C 1066 REMARK 465 LYS C 1067 REMARK 465 GLY C 1068 REMARK 465 HIS C 1069 REMARK 465 HIS C 1070 REMARK 465 HIS C 1071 REMARK 465 HIS C 1072 REMARK 465 HIS C 1073 REMARK 465 HIS C 1074 REMARK 465 LEU C 1075 REMARK 465 VAL C 1076 REMARK 465 PRO C 1077 REMARK 465 ARG C 1078 REMARK 465 GLY C 1079 REMARK 465 SER C 1080 REMARK 465 ARG C 1081 REMARK 465 LYS C 1082 REMARK 465 LYS C 1083 REMARK 465 GLY C 1197 REMARK 465 MET D 1065 REMARK 465 LYS D 1066 REMARK 465 LYS D 1067 REMARK 465 GLY D 1068 REMARK 465 HIS D 1069 REMARK 465 HIS D 1070 REMARK 465 HIS D 1071 REMARK 465 HIS D 1072 REMARK 465 HIS D 1073 REMARK 465 HIS D 1074 REMARK 465 LEU D 1075 REMARK 465 VAL D 1076 REMARK 465 PRO D 1077 REMARK 465 ARG D 1078 REMARK 465 GLY D 1079 REMARK 465 SER D 1080 REMARK 465 ARG D 1081 REMARK 465 LYS D 1082 REMARK 465 LYS D 1083 REMARK 465 GLY D 1197 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A1084 CG1 CG2 CD1 REMARK 470 GLN A1092 OE1 NE2 REMARK 470 LYS B1083 CG CD CE NZ REMARK 470 ILE C1084 CG1 CG2 CD1 REMARK 470 ILE D1084 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B1173 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B1173 NE - CZ - NH2 ANGL. DEV. = -3.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A1195 52.59 -119.74 REMARK 500 REMARK 500 REMARK: NULL DBREF 7XM7 A 1081 1197 UNP Q92793 CBP_HUMAN 1081 1197 DBREF 7XM7 B 1081 1197 UNP Q92793 CBP_HUMAN 1081 1197 DBREF 7XM7 C 1081 1197 UNP Q92793 CBP_HUMAN 1081 1197 DBREF 7XM7 D 1081 1197 UNP Q92793 CBP_HUMAN 1081 1197 SEQADV 7XM7 MET A 1065 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS A 1066 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS A 1067 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY A 1068 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS A 1069 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS A 1070 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS A 1071 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS A 1072 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS A 1073 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS A 1074 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LEU A 1075 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 VAL A 1076 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 PRO A 1077 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 ARG A 1078 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY A 1079 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 SER A 1080 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 MET B 1065 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS B 1066 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS B 1067 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY B 1068 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS B 1069 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS B 1070 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS B 1071 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS B 1072 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS B 1073 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS B 1074 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LEU B 1075 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 VAL B 1076 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 PRO B 1077 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 ARG B 1078 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY B 1079 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 SER B 1080 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 MET C 1065 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS C 1066 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS C 1067 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY C 1068 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS C 1069 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS C 1070 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS C 1071 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS C 1072 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS C 1073 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS C 1074 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LEU C 1075 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 VAL C 1076 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 PRO C 1077 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 ARG C 1078 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY C 1079 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 SER C 1080 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 MET D 1065 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS D 1066 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LYS D 1067 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY D 1068 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS D 1069 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS D 1070 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS D 1071 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS D 1072 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS D 1073 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 HIS D 1074 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 LEU D 1075 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 VAL D 1076 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 PRO D 1077 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 ARG D 1078 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 GLY D 1079 UNP Q92793 EXPRESSION TAG SEQADV 7XM7 SER D 1080 UNP Q92793 EXPRESSION TAG SEQRES 1 A 133 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 A 133 ARG GLY SER ARG LYS LYS ILE PHE LYS PRO GLU GLU LEU SEQRES 3 A 133 ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU TYR ARG SEQRES 4 A 133 GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO VAL ASP SEQRES 5 A 133 PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE VAL SEQRES 6 A 133 LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG LYS LEU SEQRES 7 A 133 ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL ASP SEQRES 8 A 133 ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU TYR ASN SEQRES 9 A 133 ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER LYS LEU SEQRES 10 A 133 ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL MET GLN SEQRES 11 A 133 SER LEU GLY SEQRES 1 B 133 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 B 133 ARG GLY SER ARG LYS LYS ILE PHE LYS PRO GLU GLU LEU SEQRES 3 B 133 ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU TYR ARG SEQRES 4 B 133 GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO VAL ASP SEQRES 5 B 133 PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE VAL SEQRES 6 B 133 LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG LYS LEU SEQRES 7 B 133 ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL ASP SEQRES 8 B 133 ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU TYR ASN SEQRES 9 B 133 ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER LYS LEU SEQRES 10 B 133 ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL MET GLN SEQRES 11 B 133 SER LEU GLY SEQRES 1 C 133 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 C 133 ARG GLY SER ARG LYS LYS ILE PHE LYS PRO GLU GLU LEU SEQRES 3 C 133 ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU TYR ARG SEQRES 4 C 133 GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO VAL ASP SEQRES 5 C 133 PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE VAL SEQRES 6 C 133 LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG LYS LEU SEQRES 7 C 133 ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL ASP SEQRES 8 C 133 ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU TYR ASN SEQRES 9 C 133 ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER LYS LEU SEQRES 10 C 133 ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL MET GLN SEQRES 11 C 133 SER LEU GLY SEQRES 1 D 133 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS LEU VAL PRO SEQRES 2 D 133 ARG GLY SER ARG LYS LYS ILE PHE LYS PRO GLU GLU LEU SEQRES 3 D 133 ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU TYR ARG SEQRES 4 D 133 GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO VAL ASP SEQRES 5 D 133 PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE VAL SEQRES 6 D 133 LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG LYS LEU SEQRES 7 D 133 ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL ASP SEQRES 8 D 133 ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU TYR ASN SEQRES 9 D 133 ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER LYS LEU SEQRES 10 D 133 ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL MET GLN SEQRES 11 D 133 SER LEU GLY HET GAY A1201 30 HET GOL A1202 6 HET GAY B1201 30 HET NO3 B1202 4 HET DMS B1203 4 HET PEG C1201 7 HET NO3 C1202 4 HET EDO D1201 4 HET EDO D1202 4 HETNAM GAY 3-ETHANOYL-~{N}-[2-FLUORANYL-3-(1-METHYLPYRAZOL-4-YL) HETNAM 2 GAY PHENYL]-7-METHOXY-INDOLIZINE-1-CARBOXAMIDE HETNAM GOL GLYCEROL HETNAM NO3 NITRATE ION HETNAM DMS DIMETHYL SULFOXIDE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM EDO 1,2-ETHANEDIOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 5 GAY 2(C22 H19 F N4 O3) FORMUL 6 GOL C3 H8 O3 FORMUL 8 NO3 2(N O3 1-) FORMUL 9 DMS C2 H6 O S FORMUL 10 PEG C4 H10 O3 FORMUL 12 EDO 2(C2 H6 O2) FORMUL 14 HOH *72(H2 O) HELIX 1 AA1 LYS A 1086 ARG A 1103 1 18 HELIX 2 AA2 SER A 1108 ARG A 1112 5 5 HELIX 3 AA3 ASP A 1124 VAL A 1129 1 6 HELIX 4 AA4 ASP A 1134 GLY A 1145 1 12 HELIX 5 AA5 GLU A 1149 ASN A 1168 1 20 HELIX 6 AA6 SER A 1172 SER A 1195 1 24 HELIX 7 AA7 LYS B 1086 ARG B 1103 1 18 HELIX 8 AA8 SER B 1108 ARG B 1112 5 5 HELIX 9 AA9 ASP B 1124 VAL B 1129 1 6 HELIX 10 AB1 ASP B 1134 THR B 1144 1 11 HELIX 11 AB2 GLU B 1149 ASN B 1168 1 20 HELIX 12 AB3 SER B 1172 GLN B 1194 1 23 HELIX 13 AB4 LYS C 1086 ARG C 1103 1 18 HELIX 14 AB5 ASP C 1116 GLY C 1121 1 6 HELIX 15 AB6 ASP C 1124 VAL C 1129 1 6 HELIX 16 AB7 ASP C 1134 THR C 1144 1 11 HELIX 17 AB8 GLU C 1149 ASN C 1168 1 20 HELIX 18 AB9 SER C 1172 LEU C 1196 1 25 HELIX 19 AC1 LYS D 1086 GLN D 1104 1 19 HELIX 20 AC2 SER D 1108 ARG D 1112 5 5 HELIX 21 AC3 ASP D 1116 GLY D 1121 1 6 HELIX 22 AC4 ASP D 1124 VAL D 1129 1 6 HELIX 23 AC5 ASP D 1134 THR D 1144 1 11 HELIX 24 AC6 GLU D 1149 ASN D 1168 1 20 HELIX 25 AC7 SER D 1172 SER D 1195 1 24 CISPEP 1 ASP A 1105 PRO A 1106 0 7.18 CISPEP 2 ASP B 1105 PRO B 1106 0 7.25 CISPEP 3 ASP C 1105 PRO C 1106 0 5.72 CISPEP 4 ASP D 1105 PRO D 1106 0 14.89 CRYST1 53.969 90.180 59.110 90.00 111.50 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018529 0.000000 0.007299 0.00000 SCALE2 0.000000 0.011089 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018183 0.00000